10.1016/s1367-5931(00)00229-5
Crossref journal-article
Elsevier BV
Current Opinion in Chemical Biology (78)
Bibliography

Caron, P. R., Mullican, M. D., Mashal, R. D., Wilson, K. P., Su, M. S., & Murcko, M. A. (2001). Chemogenomic approaches to drug discovery. Current Opinion in Chemical Biology, 5(4), 464–470.

Authors 6
  1. Paul R Caron (first)
  2. Michael D Mullican (additional)
  3. Robert D Mashal (additional)
  4. Keith P Wilson (additional)
  5. Michael S Su (additional)
  6. Mark A Murcko (additional)
References 39 Referenced 138
  1. 10.1038/35057062 / Nature / Initial sequencing and analysis of the human genome by Lander (2001)
  2. 10.1126/science.1058040 / Science / The sequence of the human genome by Venter (2001)
  3. {'key': '10.1016/S1367-5931(00)00229-5_BIB3', 'series-title': 'Human Disease — from Genetic Causes to Biochemical Effects', 'first-page': '5', 'author': 'Drews', 'year': '1997'} / Human Disease — from Genetic Causes to Biochemical Effects by Drews (1997)
  4. 10.1038/nbt1297-1318 / Nat Biotechnol / The role of innovation in drug development by Drews (1997)
  5. Incyte and Vertex Enter Genomic Partnership to Accelerate Drug Discovery in Multi-target Gene Families Using LifeSeq Gold on World Wide Web URL: http://www.vpharm.com/Pressreleases2000/pr022900.html
  6. 10.1016/S0968-0896(98)00126-6 / Bioorg Med Chem / Chemical genetics resulting from a passion for synthetic organic chemistry by Schreiber (1998)
  7. 10.1146/annurev.pharmtox.40.1.177 / Annu Rev Pharmacol Toxicol / Drug discovery in the next millennium by Ohlstein (2000)
  8. {'issue': 'Supp 7', 'key': '10.1016/S1367-5931(00)00229-5_BIB8', 'first-page': '5', 'article-title': 'Systematization of Research', 'volume': '384', 'author': 'Lehman', 'year': '1996', 'journal-title': 'Nature'} / Nature / Systematization of Research by Lehman (1996)
  9. 10.1016/S1074-5521(99)80013-1 / Chem Biol / Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era by Frye (1999)
  10. 10.2174/1386207003331472 / Comb Chem High Throughput Screen / Forecasting roles of combinatorial chemistry in the age of genomically derived drug discovery targets by Thorpe (2000)
  11. 10.1146/annurev.pharmtox.40.1.193 / Annu Rev Pharmacol Toxicol / The impact of genomics on drug discovery by Debouck (2000)
  12. 10.1016/S1074-5521(97)90194-0 / Chem Biol / The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase by Wilson (1997)
  13. 10.1021/bi981591x / Biochemistry / Molecular basis for p38 protein kinase inhibitor specificity by Lisnock (1998)
  14. 10.1002/pro.5560071102 / Protein Sci / A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase by Fox (1998)
  15. 10.1074/jbc.273.25.15605 / J Biol Chem / Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket by Gum (1998)
  16. 10.1002/prot.1057 / Proteins / Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes by Mahalingam (2001)
  17. 10.1110/ps.9.10.1898 / Protein Sci / Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance by Hong (2000)
  18. 10.1126/science.280.5360.69 / Science / The structure of the potassium channel: molecular basis of K+ conduction and selectivity by Doyle (1998)
  19. 10.1126/science.289.5480.739 / Science / Crystal structure of rhodopsin: a G protein-coupled receptor by Palczewski (2000)
  20. 10.1038/35055559 / Nature / The gating mechanism of the large mechanosensitive channel MscL by Sukharev (2001)
  21. 10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.0.CO;2-2 / Med Res Rev / ATP site-directed competitive and irreversible inhibitors of protein kinases by Garcia-Echeverria (2000)
  22. 10.1016/S1367-5931(99)80067-2 / Curr Opin Chem Biol / The development and therapeutic potential of protein kinase inhibitors by Cohen (1999)
  23. 10.1006/jmbi.1998.2369 / J Mol Biol / Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine by Lamers (1999)
  24. 10.1016/S0955-0674(96)80067-6 / Curr Opin Cell Biol / Regulation of transcription by MAP kinase cascades by Treisman (1996)
  25. 10.1111/j.1749-6632.1998.tb08307.x / Ann New York Acad Sci / Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme by Dinarello (1998)
  26. 10.1016/S0197-0186(99)00061-3 / Neurochem Int / Recent advances on neuronal caspases in development and neurodegeneration by Marks (1999)
  27. 10.1016/S1074-5521(00)00123-X / Chem Biol / The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity by Wei (2000)
  28. 10.1016/S0169-409X(96)00423-1 / Adv Drug Deliv Rev / Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings by Lipinski (1997)
  29. 10.1016/S1359-6446(97)01163-X / Drug Discov Today / Virtual screening: an overview by Walters (1998)
  30. {'year': '2000', 'series-title': 'Library Filtering Systems and Prediction of Drug-Like Properties', 'key': '10.1016/S1367-5931(00)00229-5_BIB30'} / Library Filtering Systems and Prediction of Drug-Like Properties (2000)
  31. 10.1021/jm970666c / J Med Chem / Can we learn to distinguish between ‘drug-like’ and ‘nondrug-like’ molecules? by Ajay (1998)
  32. 10.1021/jm990017w / J Med Chem / Designing libraries with CNS activity by Ajay (1999)
  33. 10.1021/jm9602928 / J Med Chem / The properties of known drugs. 1. Molecular frameworks by Bemis (1996)
  34. 10.1021/jm9903996 / J Med Chem / Properties of known drugs. 2. Side chains by Bemis (1999)
  35. 10.1016/S0065-7743(08)60591-6 / Ann Rep Med Chem / Structure-based drug design by Murcko (1999)
  36. 10.1021/jm990352k / J Med Chem / Consensus scoring: a method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins by Charifson (1999)
  37. 10.1016/S1074-5521(00)80022-8 / Chem Biol / The SHAPES strategy: an NMR-based approach for lead generation in drug discovery by Fejzo (1999)
  38. 10.1016/S0076-6879(02)38221-1 / Methods Enzymol / NMR-based approaches for lead generation in drug discovery by Peng (2001)
  39. 10.1126/science.287.5460.1960 / Science / Drug discovery: a historical perspective by Drews (2000)
Dates
Type When
Created 22 years, 10 months ago (Oct. 11, 2002, 4:03 a.m.)
Deposited 6 years, 4 months ago (April 25, 2019, 12:23 a.m.)
Indexed 2 months, 2 weeks ago (June 6, 2025, 5:08 a.m.)
Issued 24 years ago (Aug. 1, 2001)
Published 24 years ago (Aug. 1, 2001)
Published Print 24 years ago (Aug. 1, 2001)
Funders 0

None

@article{Caron_2001, title={Chemogenomic approaches to drug discovery}, volume={5}, ISSN={1367-5931}, url={http://dx.doi.org/10.1016/s1367-5931(00)00229-5}, DOI={10.1016/s1367-5931(00)00229-5}, number={4}, journal={Current Opinion in Chemical Biology}, publisher={Elsevier BV}, author={Caron, Paul R and Mullican, Michael D and Mashal, Robert D and Wilson, Keith P and Su, Michael S and Murcko, Mark A}, year={2001}, month=aug, pages={464–470} }